Clinical Trial Update: PLUG-IN: Pembrolizumab Combined With Enfortumab Vedotin for Advanced Melanoma Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pembrolizumab in combination with enfortumab vedotin for advanced melanoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Keytruda (Pembrolizumab) (pembrolizumab)
• Padcev (enfortumab vedotin) (enfortumab vedotin)

Snippet

Sponsor: Grupo Español Multidisciplinar de Melanoma | Conditions: Melanoma | Phase 2 | Status: RECRUITING